Sangamo BioSciences | SGMO - Trade Creditors


Sangamo BioSciences reported $10.74M in Trade Creditors for its fiscal quarter ending in June of 2025.





Trade Creditors Change Date
Alaunos Therapeutics USD 400K 213K Mar/2026
Alnylam Pharmaceuticals USD 108.02M 18.61M Jun/2026
Alterity Therapeutics Limited AUD 1.07M 203.72K Dec/2025
Amgen USD 2.86B 16.65B Jun/2026
Bayer EUR 6.39B 192M Jun/2026
BioCryst Pharmaceuticals USD 11.46M 501K Jun/2026
Biogen USD 403.9M 45.4M Jun/2026
BioMarin Pharmaceutical USD 913.67M 120.52M Jun/2026
Cipla INR 32.3B 1.95B Mar/2026
Clal Biotechnology ILS 21.05M 1.62M Dec/2021
Compugen USD 2.53M 173K Mar/2026
CSL USD 3.17B 290M Dec/2025
Gilead Sciences USD 645M 70M Mar/2026
GlaxoSmithKline GBP 14.34B 7M Jun/2026
Grifols EUR 987.75M 47.87M Dec/2025
Ionis Pharmaceuticals USD 47.7M 21.67M Jun/2026
J&J USD 9.22B 1.24B Jun/2026
Karyopharm Therapeutics USD 4.28M 276K Mar/2026
Merck USD 3.83B 36M Jun/2026
Novartis USD 4.26B 64M Jun/2026
Omeros USD 8.84M 4.42M Jun/2025
Pfizer USD 4.58B 75M Jun/2026
Roche Holding CHF 5.54B 237M Jun/2026
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sanofi EUR 23.6B 888M Jun/2026
Sarepta Therapeutics USD 50.98M 19.39M Jun/2026
Tectonic Therapeutic USD 2.55M 1.46M Mar/2026
Ultragenyx Pharmaceutical USD 39M 3M Jun/2026
Vertex Pharmaceuticals USD 3.61B 135M Jun/2026